Pseudotumor Cerebri (Idiopathic Intracranial Hypertension)

A 28 year old obese woman presents with daily headache, transient visual obscurations, pulsatile tinnitus, and diplopia. Fundoscopic examination reveals papilledema. MRI brain with MR venography shows no mass lesion or venous sinus thrombosis. Lumbar puncture demonstrates elevated opening pressure with normal cerebrospinal fluid composition. Diagnosis?

Diagnosis is Pseudotumor Cerebri, also known as Idiopathic Intracranial Hypertension (IIH).

1. Definition

Pseudotumor cerebri is a disorder characterized by elevated intracranial pressure (ICP) with:

  1. Normal brain imaging
  2. Normal CSF composition
  3. No intracranial mass lesion or hydrocephalus

It commonly presents with headache, papilledema, visual symptoms, and pulsatile tinnitus.

2. Epidemiology

  1. Most common in:
    • Obese women of childbearing age
  2. Strong association with:
    • Elevated BMI
    • Recent weight gain
  3. Female predominance (~90% in post-pubertal patients)
  4. Can also occur in:
    • Men
    • Children
    • Non-obese individuals

3. Etiology and Risk Factors

3.1 Common Associations

  1. Obesity
  2. Rapid weight gain
  3. Female sex
  4. PCOS may coexist

3.2 Medications

  1. Tetracyclines
  2. Vitamin A derivatives (e.g. isotretinoin)
  3. Danazol
  4. Growth hormone
  5. Excess vitamin A
  6. Corticosteroids/lithium may contribute in some cases

Oral contraceptive pills are not considered a strong proven cause but may coexist in some patients.

3.3 Secondary Causes to Exclude

  1. Cerebral venous sinus thrombosis
  2. Intracranial mass lesion
  3. Hydrocephalus
  4. Meningitis

4. Pathophysiology

  1. Impaired CSF absorption is the leading proposed mechanism
  2. Increased CSF production may contribute
  3. Increased intracranial venous pressure may play a role
  4. Elevated ICP compresses the optic nerve
  5. Leads to papilledema and visual dysfunction

Supportive imaging findings may include:

  • Transverse sinus stenosis
  • Empty sella
  • Optic nerve sheath distension

5. Clinical Features

5.1 Symptoms

  1. Headache (most common)
    • Often daily
    • Diffuse, frontal, or retro-orbital
    • Worse in morning
    • May worsen with Valsalva
  2. Transient visual obscurations
  3. Blurred vision
  4. Diplopia
  5. Pulsatile tinnitus
  6. Nausea/vomiting
  7. Photophobia
  8. Neck or back pain
  9. Photopsia (flashes of light)

5.2 Eye Findings

  1. Papilledema
  2. Enlarged blind spot
  3. Visual field defects
  4. Sixth nerve palsy causing horizontal diplopia

5.3 Important Clinical Feature

Neurologic examination is usually otherwise normal except for unilateral or bilateral CN VI palsy. Visual field loss is more common than reduced visual acuity.

6. Diagnosis

6.1 Ophthalmologic Evaluation

  1. Fundoscopy shows:
    • Papilledema
  2. Visual field testing (perimetry) is highly sensitive for visual loss
  3. Visual acuity testing assesses severity

6.2 Neuroimaging

  1. MRI brain with MR venography is preferred
  2. Imaging typically shows:
    • Normal brain parenchyma
    • No mass lesion
    • No hydrocephalus
  3. MRI findings that support IIH include:
    • Empty sella
    • Flattening of posterior globe
    • Distension of perioptic subarachnoid space
    • Optic nerve tortuosity
    • Transverse sinus stenosis
  4. MR venography is important to exclude:
    • Cerebral venous sinus thrombosis

6.3 Lumbar Puncture

  1. Elevated opening pressure
    • Typically >25 cm H₂O in adults

o    28 cm H₂O in children

  1. Normal CSF composition:
    • Normal glucose
    • Normal protein
    • Normal cell count
    • Negative culture/Gram stain

6.4 Additional Testing

  1. CBC may be performed to exclude:
    • Anemia
    • Hematologic disorders associated with papilledema

7. Modified Dandy Diagnostic Criteria

  1. Signs and symptoms of increased ICP
  2. No localizing neurologic deficits except possible CN VI palsy
  3. Elevated CSF opening pressure
  4. Normal CSF composition
  5. No structural cause on neuroimaging
  6. Patient awake and alert

8. Differential Diagnosis

  1. Cerebral venous sinus thrombosis
  2. Intracranial mass lesion
  3. Obstructive hydrocephalus
  4. Meningitis
  5. Subarachnoid hemorrhage
  6. Malignant hypertension
  7. Migraine

9. Management

9.1 Remove Contributing Factors

  1. Stop offending medications:
    • Tetracyclines
    • Isotretinoin
    • Danazol
  2. Treat secondary causes if identified

9.2 Weight Reduction

  1. Weight loss is one of the most effective long-term treatments
  2. Weight loss of 5–10% may induce remission

9.3 Medical Therapy

First-Line Therapy

  1. Acetazolamide
    • Carbonic anhydrase inhibitor
    • Reduces CSF production by up to 50%

Alternative/Adjunctive Therapy

  1. Topiramate
    • Helps headache control
    • Promotes weight loss
    • Has weak carbonic anhydrase activity
  2. Diuretics:
    • Furosemide
    • Chlorthalidone
  3. Steroids:
    • Reserved for severe or refractory visual loss
    • Not preferred long-term due to rebound ICP increase and weight gain

10. Lumbar Puncture

  1. Diagnostic lumbar puncture may transiently relieve symptoms
  2. Some patients improve after CSF removal
  3. Serial LPs are not preferred long-term therapy

11. Surgical Management

11.1 Optic Nerve Sheath Fenestration

Indicated for:

  1. Progressive visual loss
  2. Severe papilledema refractory to medical therapy

Relieves pressure on the optic nerve and protects vision.

11.2 CSF Diversion Procedures

  1. Ventriculoperitoneal (VP) shunt
  2. Lumboperitoneal shunt

More effective for headache relief than visual recovery

12. Complications

  1. Permanent visual loss
  2. Chronic headaches
  3. Persistent papilledema
  4. Diplopia
  5. Visual field defects

Treatment-related complications:

  • Hypokalemia with acetazolamide/diuretics
  • Post-LP headache
  • Surgical complications

13. Prognosis

  1. Many patients improve with:
    • Weight loss
    • Acetazolamide
  2. Early treatment improves visual outcomes
  3. Delayed treatment may lead to irreversible blindness
  4. Symptoms may persist for months to years despite therapy

14. Key Clinical Insight

Young obese woman + headache + papilledema + pulsatile tinnitus + elevated LP opening pressure + normal imaging strongly suggests Idiopathic Intracranial Hypertension

15. Exam-Level Pearls

  1. Also called: Pseudotumor cerebri
  2. Most common patient profile: Obese woman of childbearing age
  3. Most important physical finding: Papilledema
  4. Most common symptom: Headache
  5. CSF findings: Elevated opening pressure with normal composition
  6. CN VI palsy may cause: Horizontal diplopia
  7. First-line medication: Acetazolamide
  8. Pulsatile tinnitus is a classic symptom
  9. MRI + MRV are important to exclude: Cerebral venous sinus thrombosis
  10. Vision-threatening disease may require: Optic nerve sheath fenestration or VP shunt
By Prabin Duwadee at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)